Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jun;37(6):559-62.
doi: 10.1111/j.1365-2125.1994.tb04304.x.

Decreased plasma protein binding of valproate in patients with acute head trauma

Affiliations

Decreased plasma protein binding of valproate in patients with acute head trauma

G D Anderson et al. Br J Clin Pharmacol. 1994 Jun.

Abstract

1. One hundred and ten plasma samples were obtained from 50 patients treated with valproate for prophylaxis of post-traumatic head injuries. The samples were selected to include a wide range of albumin concentrations and were assayed for free and total valproate concentrations. Valproate binding parameters were determined from the Scatchard equation for one binding site using reweighted least squares analysis. 2. Plasma albumin concentrations were measured in 130 patients with head trauma. They started to decrease immediately after trauma, reaching a minimum at 5-7 days of approximately 24% of baseline value and did not return to normal until 1 month. 3. The free fraction of valproate varied six to seven-fold as albumin concentration ranged from 1.5 to 4.8 g 100 ml-1 (218-696 mumol l-1). The mean association constant for binding (Ka) was 0.008 mumol l(-1) and the mean number of binding sites (N) was 2.0. There values were similar to those reported for valproate in otherwise healthy patients with epilepsy. 4. Because of saturable protein binding of valproate, hypoalbuminaemia may necessitate the monitoring of free valproate concentrations to avoid toxicity when valproate is used in patients with acute head injury.

PubMed Disclaimer

References

    1. Ther Drug Monit. 1992 Oct;14(5):376-9 - PubMed
    1. Ther Drug Monit. 1992 Oct;14(5):349-53 - PubMed
    1. Br J Clin Pharmacol. 1978 May;5(5):441-6 - PubMed
    1. Neurology. 1980 May;30(5):557-9 - PubMed
    1. Ther Drug Monit. 1979;1(1):105-16 - PubMed

Publication types

LinkOut - more resources